Centers for Disease Control and Prevention
In the U.S. each year, the bacteria and fungi included in CDC's
            AR Threats Report result in 9.7 million infections and 50,800
            deaths

Welcome to the Antimicrobial Resistance Threats Report

Antimicrobial resistance (AR), also known as drug resistance, is an urgent global public health threat. AR happens when pathogens (germs) like bacteria and fungi develop the ability to defeat the drugs designed to kill them, resulting in infections that can be difficult or impossible to treat. If antibiotics and antifungals lose their effectiveness, then we lose the ability to treat infections and control public health threats.

At CDC, we know that high-quality data are essential to help guide policy, investments, and interventions to combat AR. The Antimicrobial Resistance Threats Report provides burden estimates for a list of bacterial and fungal pathogens categorized by level of threat to human health in the United States—urgent, serious, and concerning—and the overall domestic burden estimate for these threats. In addition, the report includes a Watch List of pathogens whose full burden is not yet understood in the United States. These pathogens are being monitored and may be included as urgent, serious, or concerning threats in the future.